Continuous intrapartum fetal monitoring in gestational diabetes, where is the evidence?

Salma Jabak, Aisha Hameed

Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2022;35(22):4354-4357

PMID: 33307915

Abstract

Gestational Diabetes Mellitus (GDM) is one of the commonest complications in the pregnancy. It differs in pathogenesis and complications from pre gestational diabetes (PGD), yet the choices of birth and management options for women in labor do not differ between both entities. We have performed literature search to find any evidence behind these recommendations specifically to the subset of pregnant women who have developed diet-controlled GDM, with normal fetal growth. There have been no randomized control trials behind these recommendations. The aforementioned women have comparable outcomes to pregnant women who are not affected by diabetes and can be considered as low risk till any evidence is found. So there is an urgent need to conduct randomized controlled trials on women with well-controlled GDM and normal fetal growth scans so that these women could be provided evidence-based information on their options of birth.

Address: Division of Obstetrics and Gynecology, Princess Royal University Hospital King's College NHS Foundation Trust, London, United Kingdom.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.